RYAM Reports Second Quarter 2026 Results

RAYONIER ADVANCED MATERIALS INC. (RYAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. RYAM Reports Second Quarter 2026 Results Strategic review remains the top priority; momentum builds into the second half • Net Sales increased 18% from the first quarter to $376 million and were up 11% from the prior-year quarter • Loss from Continuing Operations improved to $33

Original reporting
Published Aug 4, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RYAM
Bullish
medium confidence
Mentioned
$RYAM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RYAMBullishMed
01

Why it matters

The filing provides quantified Q2 operating performance (net loss, adjusted EBITDA, pricing and volume drivers) and a concrete near-term corporate catalyst: management expects to conclude the strategic review and communicate a clear path forward during Q4.

02

Market read

Traders can use the Q2 sequential improvement and the Q4 strategic-review completion timeline to update expectations for valuation, potential transactions, and risk around execution.

03

What to watch

Cellulose Specialties volume declined while pricing rose; traders may focus on whether volume weakness is structural (market share) or temporary (execution of CS leadership initiatives and customer timing).

Relevance 7/10Novelty 7/10Timing: Q2 results filed Aug 4, with strategic review expected to conclude and be communicated during Q4.

Background

The 8-K (Item 2.02) includes an EX-99.1 press release for Rayonier Advanced Materials’ second quarter ended June 27, 2026, alongside commentary that a strategic review of alternatives remains the top priority.

Company-level read

Ticker impact

$RYAMBullishMedium confidence
Context

RYAM reported Q2 2026 results with net loss of $33M, adjusted EBITDA of $40M, and said its strategic review will conclude in Q4.

Expected impact

Near-term bias modestly positive if investors believe the Q4 path-forward communication increases probability of value-maximizing outcomes; downside risk if margins/FCF trajectory or review outcomes disappoint.

Evidence & confidence

The filing is a primary earnings-style disclosure (8-K with EX-99.1) including quantified operating metrics and an explicit Q4 catalyst (completion and communication of strategic review). However, the excerpt does not provide full-year guidance numbers or consensus comparisons, limiting precision on magnitude.

Market effects

Signals improving pricing and operating rates in cellulose specialty markets, which may affect sentiment for adjacent pulp and paper supply chains.

Limited direct regional read-through beyond Jacksonville-based corporate reporting.

Highlights demand and pricing dynamics influenced by global commodity pricing and tariff/geopolitical uncertainty, relevant to global pulp pricing expectations.

Counterpoint

Despite improved adjusted EBITDA, the company still reported a $33M net loss and included a $13M non-cash impairment, so equity upside may be capped until cash flow and impairments normalize.

Key entities

  • Rayonier Advanced Materials Inc.

    Subject of the SEC 8-K, reporting Q2 2026 results and strategic review timeline.

  • Daniel M. Krawczyk

    CEO quoted emphasizing operational improvements and urgency to conclude the strategic alternatives review in Q4.

Related articles

$RYAMMedAI 8/10

Rayonier Advanced Materials Q3 Earnings Call Highlights

Rayonier Advanced Materials (RYAM) reported Q3 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose to $52M. High Purity Cellulose sales increased, while Paperboard & High Yield Pulp sales declined. The company is focusing on its Cellulose Specialties franchise and expects positive free cash flow for 2026, subject to certain conditions.

$RYAMMed

Rayonier Advanced Materials Inc (RYAM) Q3 2026 Earnings Call Highlights: HPC Segment

Rayonier Advanced Materials (RYAM) reported Q3 2026 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose 30% to $52M. CEO Dan Kraupchak discussed strategic plans, including optimizing production mix and pursuing longer-term customer agreements. CFO Marcus Moltner noted $4M energy credits and $2M tariff-related costs. CS volumes are expected to exit the year at ~100,000 metric tons per quarter. Liquidity stands at $143M, with positive adjusted free cash flow of $2M YTD.

$RYAMHighAI 8/10

Rayonier Advanced Materials 3Q 2026: Revenue $382.51M, Net income ($229.77M), EPS ($3.4) — 10-Q Summary

Rayonier Advanced Materials reported 3Q 2026 revenue of $382.51M, up 8.4% YoY, but net loss widened to $229.77M. EPS loss was $3.4. Sales growth was driven by higher cellulose specialties pricing and increased volumes. The company idled uneconomic operations at Temiscaming and is targeting CS-focused production growth. A strategic review is expected to complete in Q1 2027.

$RYAMMed

RYAM Reports Third Quarter 2026 Results

RAYONIER ADVANCED MATERIALS INC. (RYAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. RYAM Reports Third Quarter 2026 Results Delivers 30% sequential growth in Adjusted EBITDA Temiscaming production economically idled following U.S. tariffs • Loss from Continuing Operations of $229 million adjusted for non-cash impairments of $221 million was $8 million, a 60% seq

$RYAMHighAI 8/10

RYAM Reports Third Quarter 2026 Results

Rayonier Advanced Materials (RYAM) reported Q3 2026 results. HPC income rose to $29M with Adjusted EBITDA of $44M, while Temiscaming operations were idled. Consolidated Adjusted EBITDA was $52M, including tariff costs. The company aims to conclude its strategic review in Q1 2027. Net sales were $383M, with HPC at $313M and Paperboard & High Yield Pulp at $70M. Operating loss was $196M, including non-cash impairments. Year-to-date Adjusted Free Cash Flow was $66M.

$RYAMMed

Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another Story

Rayonier Advanced Materials (RYAM) reported Q2 net sales of $376M, up 18% QoQ and 11% YoY, with a narrowed loss of $33M. High Purity Cellulose segment saw a 21% YoY price increase, boosting operating income by 45%. However, Cellulose Specialties volume fell 23% YoY. Management maintains a 2026 outlook for positive free cash flow and targets Q4 2026 for a strategic review conclusion.